CyberKnife System Broadens Range of Lung Cancer Patients Treatable with SBRT SUNNYVALE, Calif. , Jan. 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today publication of a study demonstrating the benefits of the CyberKnife® Robotic
Data provides new support for efficacy and toxicity benefits of non-invasively delivering High Dose Rate Brachytherapy dosing to patients with prostate cancer SUNNYVALE, Calif. , Jan. 9, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today
CyberKnife Frameless Radiosurgery Offers a Precise and Non-Invasive Technique with Clinical Outcomes Similar to Gamma Knife Frame-Based Invasive Radiosurgery SUNNYVALE, Calif. , Jan. 29, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a study of 138 patients
Fifth Users' Meeting Highlights Efficacy of TomoTherapy® Treatment System and Widespread Acceptance Across the Region SUNNYVALE, Calif. , Oct. 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, showcased new clinical research on its TomoTherapy ®
Freestanding Center is First in the Western U.S. to Treat Patients with this "Smart" Radiation Therapy Delivery System with Fully-Integrated Treatment Planning and Data Management Systems SUNNYVALE, Calif. , Aug. 17, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the Summit Cancer
SUNNYVALE, Calif., March 19 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY - News), a global leader in the field of radiosurgery, announced today the results of an independent survey that confirms that the CyberKnife® Robotic Radiosurgery System dominates the field of extracranial
First Multi-System Agreement by a Hospital for Both Accuray and RaySearch Products The Swiss Medical Network, Accuray and RaySearch Have Also Partnered to Expand Opportunities for Training Healthcare Professionals on the Latest Technologies SUNNYVALE, Calif.
Versatile, Easy-to-Use System Offers Patients Access to Technologically Advanced Cancer Care SUNNYVALE, Calif. , Oct. 9, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Klinikum rechts der Isar der Technischen Universität München (TUM) clinical team has treated the
Next-Generation "Smart" TomoTherapy® System Represents Major Step Forward in Treatment Speed, Ease of Use and Adaptive Therapy Capabilities SUNNYVALE, Calif. , Feb. 8, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that it has received Shonin approval from the Japanese
Where experience and state-of-the-art technology meet SUNNYVALE, Calif. , April 7, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the European CyberKnife Center Munich-Grosshadern (ECZM) has performed 5,000 CyberKnife® treatments since June 2005 .
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
